Rani Therapeutics offers breakthrough capsule for patients with chronic conditions

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma

Rani Therapeutics prices $73M IPO for robotic drug-delivery pill tech